Cognizant has announced a multi-year, multi-million dollar engagement with Merck & Co. Cognizant will extend its existing relationship with Merck to become a key technology partner and provide a full suite of services encompassing applications outsourcing, IT infrastructure management and business process outsourcing services.
“Over the past two years, Merck has leveraged Cognizant’s extensive pharmaceutical expertise to streamline operational efficiencies and to consolidate our IT portfolio,” said Rich Branton, vice president - Global Technology Solutions, Merck & Co. “We selected Cognizant as our ongoing strategic partner for the full suite of IT services as a result of our previous engagements and Cognizant’s deep domain experience and leadership position in our space.”
“With Cognizant’s expertise in the Healthcare and Life Sciences industry, we are proud to be chosen by Merck as a trusted IT partner to deliver services globally for them,” said Francisco D’Souza, president and CEO of Cognizant. “Our ability to integrate applications, infrastructure and business processes, coupled with our global delivery model, enables us to provide Merck with a strong platform for its global transformational initiatives.”